Bio-Techne (TECH)

• Market cap: $9.28B
• 1 day: -2.04%
• 5 days: -3.26%
• 1 month: -4.89%
• 3 months: -18.76%
• 6 months: -26.52%
• Year to date: -17.84%
• 1 year: -16.56%
• 5 years: 392.70%
• 10 years: 833.70%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

921% more call options, than puts

Call options by funds: $12.9M | Put options by funds: $1.27M

40% more first-time investments, than exits

New positions opened: 70 | Existing positions closed: 50

13% more repeat investments, than reductions

Existing positions increased: 217 | Existing positions reduced: 192

3.6% more ownership

Funds ownership: 96.73% [Q3] → 100.34% (+3.6%) [Q4]

2% more funds holding

Funds holding: 554 [Q3] → 563 (+9) [Q4]

7% less capital invested

Capital invested by funds: $12.3B [Q3] → $11.5B (-$808M) [Q4]

40% less funds holding in top 10

Funds holding in top 10: 10 [Q3] → 6 (-4) [Q4]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $68 16% upside
• Avg. target: $79 34% upside
• High target: $90 53% upside

6 analyst ratings

• positive: 3 50%
• neutral: 3 50%
• negative: 0 0%

Evercore ISI Group Daniel Markowitz 0% 1-year accuracy 0 / 2 met price target	28% upside $75	Outperform Initiated	18 Mar 2025
Citigroup Patrick Donnelly 23% 1-year accuracy 7 / 31 met price target	19% upside $70	Neutral Maintained	4 Mar 2025
Baird Catherine Schulte 0% 1-year accuracy 0 / 20 met price target	16% upside $68	Neutral Downgraded	19 Feb 2025
RBC Capital Conor McNamara 5% 1-year accuracy 2 / 37 met price target	36% upside $80	Sector Perform Maintained	6 Feb 2025
Scotiabank Sung Ji Nam 17% 1-year accuracy 4 / 24 met price target	53% upside $90	Sector Outperform Maintained	6 Feb 2025